{"title":"ACE2、TMPRSS2、TYK2、SLC6A20和IFNAR2基因变异对SARS-CoV-2感染易感性的影响","authors":"Seyedeh Sepideh Aghamirli , Mohammad Zarif , Marzieh Khalouei , Kolsoum Saeidi , Nasrollah Saleh-Gohari","doi":"10.1016/j.genrep.2025.102228","DOIUrl":null,"url":null,"abstract":"<div><div>This cross-sectional study investigates the genetic factors influencing susceptibility to coronavirus disease 2019 (COVID-19), focusing on the role of key human genes, including <em>angiotensin-converting enzyme 2 (ACE2)</em>, <em>transmembrane serine protease 2 (TMPRSS2)</em>, <em>tyrosine kinase 2 (TYK2)</em>, <em>solute carrier family 6 member 20 (SLC6A20)</em>, and <em>interferon alpha and beta receptor subunit 2 (IFNAR2)</em>. Whole-exome sequencing was performed on a cohort of 100 individuals, both with and without a history of SARS-CoV-2 infection. A total of 140 genetic variations, including single nucleotide variations, insertions/deletions, and splicing variants, were identified across these genes. Among the variants, nine, such as rs759499720 and rs776459296 in <em>ACE2</em>, rs386818798 in <em>TMPRSS2</em>, and rs759744926 in <em>IFNAR2</em>, were found to increase the risk of COVID-19. To further explore their impact, bioinformatics homology modeling was employed to assess how these genetic changes affect the three-dimensional (3D) structure of the associated proteins, revealing functional alterations that may contribute to disease severity. These findings suggest that variations in these genes may play a critical role in the pathogenesis of COVID-19, highlighting the importance of considering genetic factors in the development of targeted treatments and vaccines for better disease management.</div></div>","PeriodicalId":12673,"journal":{"name":"Gene Reports","volume":"40 ","pages":"Article 102228"},"PeriodicalIF":1.0000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Influence of the ACE2, TMPRSS2, TYK2, SLC6A20, and IFNAR2 gene variants on susceptibility to SARS-CoV-2 infection\",\"authors\":\"Seyedeh Sepideh Aghamirli , Mohammad Zarif , Marzieh Khalouei , Kolsoum Saeidi , Nasrollah Saleh-Gohari\",\"doi\":\"10.1016/j.genrep.2025.102228\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This cross-sectional study investigates the genetic factors influencing susceptibility to coronavirus disease 2019 (COVID-19), focusing on the role of key human genes, including <em>angiotensin-converting enzyme 2 (ACE2)</em>, <em>transmembrane serine protease 2 (TMPRSS2)</em>, <em>tyrosine kinase 2 (TYK2)</em>, <em>solute carrier family 6 member 20 (SLC6A20)</em>, and <em>interferon alpha and beta receptor subunit 2 (IFNAR2)</em>. Whole-exome sequencing was performed on a cohort of 100 individuals, both with and without a history of SARS-CoV-2 infection. A total of 140 genetic variations, including single nucleotide variations, insertions/deletions, and splicing variants, were identified across these genes. Among the variants, nine, such as rs759499720 and rs776459296 in <em>ACE2</em>, rs386818798 in <em>TMPRSS2</em>, and rs759744926 in <em>IFNAR2</em>, were found to increase the risk of COVID-19. To further explore their impact, bioinformatics homology modeling was employed to assess how these genetic changes affect the three-dimensional (3D) structure of the associated proteins, revealing functional alterations that may contribute to disease severity. These findings suggest that variations in these genes may play a critical role in the pathogenesis of COVID-19, highlighting the importance of considering genetic factors in the development of targeted treatments and vaccines for better disease management.</div></div>\",\"PeriodicalId\":12673,\"journal\":{\"name\":\"Gene Reports\",\"volume\":\"40 \",\"pages\":\"Article 102228\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gene Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452014425001013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gene Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452014425001013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Influence of the ACE2, TMPRSS2, TYK2, SLC6A20, and IFNAR2 gene variants on susceptibility to SARS-CoV-2 infection
This cross-sectional study investigates the genetic factors influencing susceptibility to coronavirus disease 2019 (COVID-19), focusing on the role of key human genes, including angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), tyrosine kinase 2 (TYK2), solute carrier family 6 member 20 (SLC6A20), and interferon alpha and beta receptor subunit 2 (IFNAR2). Whole-exome sequencing was performed on a cohort of 100 individuals, both with and without a history of SARS-CoV-2 infection. A total of 140 genetic variations, including single nucleotide variations, insertions/deletions, and splicing variants, were identified across these genes. Among the variants, nine, such as rs759499720 and rs776459296 in ACE2, rs386818798 in TMPRSS2, and rs759744926 in IFNAR2, were found to increase the risk of COVID-19. To further explore their impact, bioinformatics homology modeling was employed to assess how these genetic changes affect the three-dimensional (3D) structure of the associated proteins, revealing functional alterations that may contribute to disease severity. These findings suggest that variations in these genes may play a critical role in the pathogenesis of COVID-19, highlighting the importance of considering genetic factors in the development of targeted treatments and vaccines for better disease management.
Gene ReportsBiochemistry, Genetics and Molecular Biology-Genetics
CiteScore
3.30
自引率
7.70%
发文量
246
审稿时长
49 days
期刊介绍:
Gene Reports publishes papers that focus on the regulation, expression, function and evolution of genes in all biological contexts, including all prokaryotic and eukaryotic organisms, as well as viruses. Gene Reports strives to be a very diverse journal and topics in all fields will be considered for publication. Although not limited to the following, some general topics include: DNA Organization, Replication & Evolution -Focus on genomic DNA (chromosomal organization, comparative genomics, DNA replication, DNA repair, mobile DNA, mitochondrial DNA, chloroplast DNA). Expression & Function - Focus on functional RNAs (microRNAs, tRNAs, rRNAs, mRNA splicing, alternative polyadenylation) Regulation - Focus on processes that mediate gene-read out (epigenetics, chromatin, histone code, transcription, translation, protein degradation). Cell Signaling - Focus on mechanisms that control information flow into the nucleus to control gene expression (kinase and phosphatase pathways controlled by extra-cellular ligands, Wnt, Notch, TGFbeta/BMPs, FGFs, IGFs etc.) Profiling of gene expression and genetic variation - Focus on high throughput approaches (e.g., DeepSeq, ChIP-Seq, Affymetrix microarrays, proteomics) that define gene regulatory circuitry, molecular pathways and protein/protein networks. Genetics - Focus on development in model organisms (e.g., mouse, frog, fruit fly, worm), human genetic variation, population genetics, as well as agricultural and veterinary genetics. Molecular Pathology & Regenerative Medicine - Focus on the deregulation of molecular processes in human diseases and mechanisms supporting regeneration of tissues through pluripotent or multipotent stem cells.